Immunogen | IMGN - Passivo Circulante



Passivo Circulante Alterar Data
AbbVie USD 42.1B 1.19B 2026-03
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Amgen USD 24.96B 534M 2026-03
Astellas Pharma JPY 1.22T 106.19B 2026-03
AstraZeneca USD 31.55B 1.02B 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Eli Lilly USD 36.63B 1.41B 2026-03
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Exelixis USD 370.98M 34.67M 2026-03
Halozyme Therapeutics USD 363.21M 186.12M 2026-03
Heron Therapeutics USD 90.52M 5.58M 2026-03
Intrexon USD 23.02M 38K 2024-06
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
MacroGenics USD 95.94M 52.82M 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 30.01B 1.66B 2026-03